Loading data for CSBR — first visit, this takes a few seconds.
Champions Oncology Inc. (CSBR)
NasdaqCM: CSBR
· Real-Time Price · USD
4.91
-0.07 (-1.41%)
At close: Aug 27, 2026, 8:00 PM
5.01
-0.20%
After-hours: 4:10 PM
The price, the headline numbers and the latest news, in one place.
Champions Oncology Inc. (CSBR) Stock Price, Analysis & Data
-1.41% (1D)
No data available
| Bid | 3.51 |
| Market Cap | 69.75M |
| Revenue (ttm) | 59.42M |
| Net Income (ttm) | -1.18M |
| 0.41 | |
| -0.08 | |
| n/a | |
| 50.2 | |
| P/B (ttm) | 17.68 |
| P/S (ttm) | 1.17 |
| Earnings Date | Dec 14, 2020 |
| Ask | 6.34 |
| Volume | 696 |
| Avg. Volume (20D) | 8,950 |
| Open | 4.94 |
| Previous Close | 4.98 |
| Day's Range | 4.91 - 4.94 |
| 52-Week Range | 4.83 - 8.74 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CSBR
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug deve...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 2, 2007
Employees 214
Stock Exchange NasdaqCM
Ticker Symbol CSBR
Financial Performance
In 2026, Champions Oncology's revenue was 59.42M, an increase of 4.36% compared to the previous year's 56.94M. Earnings were -1.18M, a decrease of -124.99%.
Financial StatementsEarnings Surprise
Champions Oncology has released their quarterly earnings on Dec 15, 2025:
- Revenue of $13.84M misses estimates by $0, with 11.98% YoY growth.
- EPS of 0.06 misses estimates by , with 20.00% YoY growth.
Champions Oncology Inc. is scheduled to release its earnings on Dec 14, 2020, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2